Antibody-Mediated Phosphatidylserine Blockade Enhances the Antitumor Responses to CTLA-4 and PD-1 Antibodies in Melanoma

In tumor-bearing animals, the membrane phospholipid phosphatidylserine (PS) suppresses immune responses, suggesting that PS signaling could counteract the antitumor effect of antibody-driven immune checkpoint blockade. Here, we show that treating melanoma-bearing mice with a PS-targeting antibody en...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer Immunol Res
Main Authors: Freimark, Bruce D., Gong, Jian, Ye, Dan, Gray, Michael J., Nguyen, Van, Yin, Shen, Hatch, Michaela M.S., Hughes, Christopher C.W., Schroit, Alan J., Hutchins, Jeff T., Brekken, Rolf A., Huang, Xianming
Formato: Artigo
Idioma:Inglês
Publicado: 2016
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7821912/
https://ncbi.nlm.nih.gov/pubmed/27045021
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-15-0250
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares